Annual CFF
$47.79 M
+$44.70 M+1447.67%
December 31, 2023
Summary
- As of February 7, 2025, MIST annual cash flow from financing activities is $47.79 million, with the most recent change of +$44.70 million (+1447.67%) on December 31, 2023.
- During the last 3 years, MIST annual CFF has fallen by -$25.43 million (-34.73%).
- MIST annual CFF is now -44.04% below its all-time high of $85.41 million, reached on December 31, 2019.
Performance
MIST Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$74.00 K
+$372.00 K+124.83%
September 30, 2024
Summary
- As of February 7, 2025, MIST quarterly cash flow from financing activities is $74.00 thousand, with the most recent change of +$372.00 thousand (+124.83%) on September 30, 2024.
- Over the past year, MIST quarterly CFF has dropped by -$231.00 thousand (-75.74%).
- MIST quarterly CFF is now -99.91% below its all-time high of $86.09 million, reached on June 30, 2019.
Performance
MIST Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$32.10 M
-$231.00 K-0.71%
September 30, 2024
Summary
- As of February 7, 2025, MIST TTM cash flow from financing activities is $32.10 million, with the most recent change of -$231.00 thousand (-0.71%) on September 30, 2024.
- Over the past year, MIST TTM CFF has dropped by -$15.92 million (-33.16%).
- MIST TTM CFF is now -80.69% below its all-time high of $166.19 million, reached on June 30, 2019.
Performance
MIST TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
MIST Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1447.7% | -75.7% | -33.2% |
| 3 y3 years | -34.7% | -99.8% | -39.8% |
| 5 y5 years | -40.4% | -99.8% | -39.8% |
MIST Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1447.7% | -99.8% | +102.7% | -39.8% | >+9999.0% |
| 5 y | 5-year | -44.0% | +1447.7% | -99.8% | +102.7% | -62.4% | +7062.3% |
| alltime | all time | -44.0% | +1447.7% | -99.9% | +102.7% | -80.7% | +7062.3% |
Milestone Pharmaceuticals Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $74.00 K(-124.8%) | $32.10 M(-0.7%) |
| Jun 2024 | - | -$298.00 K(-100.9%) | $32.33 M(+8.3%) |
| Mar 2024 | - | $32.32 M(>+9900.0%) | $29.86 M(-37.5%) |
| Dec 2023 | $47.79 M(+1447.7%) | $1000.00(-99.7%) | $47.79 M(-0.5%) |
| Sep 2023 | - | $305.00 K(-111.0%) | $48.02 M(-4.7%) |
| Jun 2023 | - | -$2.77 M(-105.5%) | $50.38 M(-5.5%) |
| Mar 2023 | - | $50.25 M(>+9900.0%) | $53.29 M(+1625.8%) |
| Dec 2022 | $3.09 M(-38.9%) | $227.00 K(-91.5%) | $3.09 M(+4.6%) |
| Sep 2022 | - | $2.67 M(+1808.6%) | $2.95 M(+868.2%) |
| Jun 2022 | - | $140.00 K(+185.7%) | $305.00 K(-94.0%) |
| Mar 2022 | - | $49.00 K(-46.7%) | $5.08 M(+0.6%) |
| Dec 2021 | $5.05 M | $92.00 K(+283.3%) | $5.05 M(-90.5%) |
| Sep 2021 | - | $24.00 K(-99.5%) | $53.12 M(-31.8%) |
| Jun 2021 | - | $4.92 M(>+9900.0%) | $77.91 M(+6.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $19.00 K(-100.0%) | $73.17 M(-0.1%) |
| Dec 2020 | $73.22 M(-14.3%) | $48.16 M(+94.0%) | $73.22 M(+191.9%) |
| Sep 2020 | - | $24.82 M(>+9900.0%) | $25.09 M(-5542.1%) |
| Jun 2020 | - | $172.00 K(+123.4%) | -$461.00 K(-100.5%) |
| Mar 2020 | - | $77.00 K(+266.7%) | $85.46 M(+0.1%) |
| Dec 2019 | $85.41 M(+6.6%) | $21.00 K(-102.9%) | $85.41 M(-48.4%) |
| Sep 2019 | - | -$731.00 K(-100.8%) | $165.46 M(-0.4%) |
| Jun 2019 | - | $86.09 M(>+9900.0%) | $166.19 M(+107.5%) |
| Mar 2019 | - | $25.00 K(-100.0%) | $80.11 M(-0.0%) |
| Dec 2018 | $80.11 M(+160.8%) | $80.08 M(>+9900.0%) | $80.11 M(>+9900.0%) |
| Sep 2018 | - | $0.00(-100.0%) | $37.00 K(0.0%) |
| Jun 2018 | - | $7000.00(-76.7%) | $37.00 K(+23.3%) |
| Mar 2018 | - | $30.00 K | $30.00 K |
| Dec 2017 | $30.72 M | - | - |
FAQ
- What is Milestone Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Milestone Pharmaceuticals?
- What is Milestone Pharmaceuticals annual CFF year-on-year change?
- What is Milestone Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Milestone Pharmaceuticals?
- What is Milestone Pharmaceuticals quarterly CFF year-on-year change?
- What is Milestone Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for Milestone Pharmaceuticals?
- What is Milestone Pharmaceuticals TTM CFF year-on-year change?
What is Milestone Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of MIST is $47.79 M
What is the all time high annual CFF for Milestone Pharmaceuticals?
Milestone Pharmaceuticals all-time high annual cash flow from financing activities is $85.41 M
What is Milestone Pharmaceuticals annual CFF year-on-year change?
Over the past year, MIST annual cash flow from financing activities has changed by +$44.70 M (+1447.67%)
What is Milestone Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of MIST is $74.00 K
What is the all time high quarterly CFF for Milestone Pharmaceuticals?
Milestone Pharmaceuticals all-time high quarterly cash flow from financing activities is $86.09 M
What is Milestone Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, MIST quarterly cash flow from financing activities has changed by -$231.00 K (-75.74%)
What is Milestone Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of MIST is $32.10 M
What is the all time high TTM CFF for Milestone Pharmaceuticals?
Milestone Pharmaceuticals all-time high TTM cash flow from financing activities is $166.19 M
What is Milestone Pharmaceuticals TTM CFF year-on-year change?
Over the past year, MIST TTM cash flow from financing activities has changed by -$15.92 M (-33.16%)